KPRX
NASDAQ · Pharmaceuticals
Kiora Pharmaceuticals Inc
$2.62
-0.09 (-3.32%)
Open$2.73
Previous Close$2.71
Day High$2.75
Day Low$2.62
52W High$2.95
52W Low$1.76
Volume—
Avg Volume14.6K
Market Cap11.50M
P/E Ratio—
EPS$-2.47
SectorPharmaceuticals
Analyst Ratings
Strong Buy
7 analysts
Price Target
+1,019.8% upside
Current
$2.62
$2.62
Target
$29.34
$29.34
$16.75
$29.34 avg
$32.13
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 15.53M | 8.57M | 1.95M |
| Net Income | 3.48M | 1.73M | 336.4K |
| Profit Margin | 22.4% | 21.3% | 17.3% |
| EBITDA | 4.31M | 2.26M | 564.5K |
| Free Cash Flow | — | — | 437.5K |
| Rev Growth | +81.3% | +81.3% | -4.0% |
| Debt/Equity | — | — | 0.84 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,150.99 | -1.64% | 40.7 | 1.09T |
| JNJ | Johnson & Johnson | $269.17 | -0.01% | 30.6 | 644.12B |
| MRK | Merck & Co. Inc. | $148.08 | -1.88% | 114.0 | 361.66B |
| PFE | Pfizer Inc. | $28.18 | +0.90% | 36.4 | 157.54B |
| BMY | Bristol-Myers Squibb Co | $61.15 | -1.77% | 13.9 | 128.81B |
| ZTS | Zoetis Inc | $71.61 | -1.72% | 11.5 | 30.15B |